BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23293202)

  • 1. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat.
    Song YS; Fang CH; So BI; Park JY; Jun DW; Kim KS
    Ann Hepatol; 2013; 12(1):115-22. PubMed ID: 23293202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
    Zhang J; Tan Y; Yao F; Zhang Q
    Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
    Du R; Xue J; Wang HB; Zhang Y; Xie ML
    Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
    Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCBP6 Is Involved in the Development of Hepatic Steatosis Induced by High-Fat Diet and CCL4 in Rats.
    Zheng YP; Zhong XY; Huang YS; Zheng CB
    Ann Hepatol; 2018; 17(3):511-518. PubMed ID: 29735802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
    Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
    J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats.
    Zhang B; Xue C; Hu X; Xu J; Li Z; Wang J; Yanagita T; Xue Y; Wang Y
    Lipids Health Dis; 2012 May; 11():48. PubMed ID: 22569330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
    Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].
    Chen L; Jiang M; Xin Y; Wang J; Liu Y; Jiang X; Xuan S
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):102-7. PubMed ID: 26983476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
    World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor prevents the development of hepatic steatosis in rats.
    Song YS; Joo HW; Park IH; Shen GY; Lee Y; Shin JH; Kim H; Kim KS
    Ann Hepatol; 2015; 14(2):243-50. PubMed ID: 25671834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous Extract of Pepino (
    Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats.
    Jung TS; Kim SK; Shin HJ; Jeon BT; Hahm JR; Roh GS
    Liver Int; 2012 Nov; 32(10):1565-73. PubMed ID: 22863080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
    Chen SW; Yin GL; Song CY; Meng DC; Yu WF; Zhang X; Feng YN; Liang PP; Zhang FX
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.